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AbStrACt
Kawasaki disease (KD) was first described in 1967 by Kawasaki, who defined it as “mucocutaneous lymph node syn-
drome”.
KD is an acute systemic vasculitis, which mainly involves medium calibre arteries; its origin is unknown, and it is ob-
served in children under the age of 5, especially in their third year. 
The principal presentations of KD include fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral 
mucosa, changes in the extremities, rash, and cervical lymphadenopathy.
Within KD, oral mucositis – represented by diffuse mucous membrane erythema, lip and tongue reddening and lingual 
papillae hypertrophy with subsequent development of strawberry tongue – can occur both in the acute stage of the disease 
(0-9 days), and in the convalescence stage (>25 days) as a consequence of the pharmacological treatment. KD vascular 
lesions are defined as systemic vasculitis instead of systemic arteritis. This study analyzed the anatomical-pathological 
substrata of oral mucositis in a baby affected by Kawasaki disease and suddenly deceased for cardiac tamponade caused 
by coronary aneurysm rupture (sudden cardiac death of a mechanical type). 
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INtrODUCtION
Kawasaki disease (KD) is an acute systemic vasculitis which 
mainly involves medium calibre arteries; its origin is unk-
nown, and it affects children under the age of 5, especially 
in their third year (1-5). 
Epidemiological studies and clinical presentation suggest 
an infective origin of the disease (5). Although a variety of 
infective agents have been proposed -  rickettsiae, viruses 
(Epstein-Barr virus and retrovirus), viridans streptococcus, 
staphylococci, parvovirus and propionibacterium – no speci-
fic aetiological agent has been identified so far; therefore, 
the infection is deemed to be the trigger for the disease in 
genetically susceptible subjects (substratum) (6,7). 
KD was first described in 1967 by Kawasaki, who defined 
it as “mucocutaneous lymph node syndrome” (8-10). KD 
yearly incidence in the world amounts to approximately 
3.4-100 cases/100,000 people. In Japan, the incidence of the 
disease is 10 times higher than in the United States and 30 
times higher than in Great Britain and Australia. Moreover, 
the Japanese immigrants maintain the incidence of their 
country of origin, strengthening the hypothesis of a genetic 
substratum (11,12). Today, KD diagnosis is formulated on 
the basis of a combination of distinctive clinical aspects 
(diagnostic criteria) and laboratory data (1).
The diagnostic criteria include: feverish state, which lasts 
at least 5 days and does not disappear with the usual 
antipyretic drugs (antibiotics etc.); polymorphous rash; 
conjunctival congestion; oropharyngeal mucositis (erythe-
matous and cracked lips, strawberry tongue, pharyngeal 
erythema); periungual erythema, swelling and peeling on 
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upper and lower limbs, laterocervical lymphadenitis (9,13). 
These aspects can be associated to irritability, meningism, 
diarrhoea, hepatitis, hydrops of gallbladder, urethritis, otitis 
media and arthritis (1).
The cardiac involvement, in the forms of myocarditis, peri-
carditis, coronal aneurysms, valvular failure, etc., is always 
present – even though in the latent form in some cases – and 
it is responsible for the decease from occlusive thrombosis of 
the typical vasculitic coronal aneurysms, which often occurs 
during the convalescence stage of the disease (1,14-19).
Laboratory data include leukocytosis, high ESR, positivity 
to C-reactive protein, thrombocytosis (1,20).
The observation of  numerous patients deceased from 
autopsically ascertained KD, whose diagnosis in life had 
been delayed or even not formulated due to the absence 
of  some of  the 5 diagnostic criteria, has permitted the 
identification of “atypical” or “incomplete” forms of KD 
(21,22). The latter are observed in children under the age 
of 2, and mainly in babies (<6 months). In atypical KD 
(AKD) forms, the most frequently missing symptoms are: 
cervical lymphadenopathy, mucositis and polymorphous 
exanthema. On the other hand, in AKD, all laboratory data 
are always present (23,24).
The clinical course of KD can be divided into 3 clinical 
stages (Table 1): acute, subacute and convalescence (1). The 
acute feverish stage usually lasts from 7 to 14 days (after 
which temperature returns to normal), and is characterized 
by conjunctival congestion, oropharyngeal mucositis, pe-
riungual erythema and peeling, polymorphous rash and la-
terocervical lymphadenopathy. The subacute stage includes 
the period between the end of the feverish and the 25th day 
of the disease. During this stage, the patients show skin pe-
eling on the limbs, arthritis, arthralgia and thrombocytosis. 
The convalescence stage begins when the clinical symptoms 
start disappearing, and continues till ESR normalization, 
which is observed after 6 to 8 weeks (1,25).
Anatomical-pathological studies have shown how the clini-
cal manifestations of KD depend on specific morphological 
substrata detectable at the cardiovascular level, which, 
according to their chrono-histogenesis, have permitted the 
formulation of an accurate stage classification (14).
KD is very rare in non Oriental children having less than 
6 months.
This study analyzed the anatomical-pathological substrata 
of oral mucositis in a 3 month-old Italian baby affected 
by Kawasaki disease and suddenly deceased for cardiac 
tamponade caused by coronary aneurysm rupture (sudden 
cardiac death of a mechanical type).
CASE rEPOrt 
This case regards a 3 month-old Italian male baby who, three 
days after the compulsory vaccination (I dose of antipolio, 
anti-hepatitis B, anti-diphteric and antipneumonia vaccina-
tion) and antipyretic administration (Lonarid®) to calm the 
feverish condition caused by this, gradually showed eyelid 
conjunctival and lip erythema, diffuse cutaneous exanthema 
and pharingo-tonsillitis associated to crises of staring which 
lasted for a few seconds. For the latter reason, the baby was 
hospitalized in the Pediatrics and Neonatology Division. 
At admission, his temperature was 39°C; leukocytes 7,500; 
transaminases 100 (GOT), 79 (ALT), 192 (Gamma-GT).
On the following day, given the unvaried clinical situation, 
which mainly showed high temperature and multiarea 
erythemas, the baby was transferred to the Infectious 
Disease Division for suspected sepsis. At admission, he 
underwent antibiotic therapy (Rocefin®) associated to 
cortisone (Bentelan®-1mg-die) for the presence of diffuse 
hoarse breathing with oropharyngitis; the haemato-che-
mical data were: erythrocytes 3.51x10e6/uL; leukocytes 
9.92x10e3/uL; platelets 626x10e3/uL; alcaline phosphatase 
334 IU/L, PCR 7.85mg/dl; ALT 49IU/L. The other clini-
cal manifestations described above remained unchanged. 
Further haemato-chemical tests excluded the presence of 
infections due to cytomegalovirus, toxoplasma, hepatitis 
virus and listeria; an abdominal ecography was carried out, 
which merely revealed a hepatosplenomegaly with an even 
parenchymal structure. On the third day after admission, 
due to the appearance of skin pallor, pained expression, 
perioral cyanosis, alae nasi agitation, medium bubble rales 
at the right middle pulmonary lobe, presence of skin fovea 
at the palpation of the lower limbs, an echocardiogram was 
carried out, which showed: diffusely hyperechogenic right 
coronary, dilated in the proximal tract with 4 mm aneurismal 
margin; hyperechogenic left coronary, dilated at the level of 
the common trunk, with aneurysmatic aspect at the level 
of the first tract of anterior interventricular septum (AIV); 
moderate pericardial effusion; widely preserved myocardial 
Stage 1 (0-9 days) 
- microvascular angiitis 
- acute endoarteritis and perivasculitis of main coronaries 
- pericarditis, valvulitis and endocarditis 
- myocarditis with and without specific myocardium 
involvement 
Causes of death: heart failure and arrythmia 
 
Stage 2 (12-25 days) 
- panvasculitis of main coronaries, with aneurysms and 
thrombi 
- intimal coronary proliferation 
- myocarditis, pericarditis and endocarditis 
Causes of death: the same as in stage 1, plus myocardial 
infarction and aneurysm rupture 
 
Stage 3 (28-31 days) 
- bead-like coronaries 
- marked intimal coronary thickening 
- disappearance of microvascular angiitis 
Causes of death: myocardial infarction 
 
Stage 4 (40 days-4 years) 
- cicatrisation, stenosis, calcification and re-canalization 
of main coronaries 
- endocardial and myocardial fibrosis 
Causes of death: myocardial infarction 
table 1. Kawasaki Disease: Stage Classification.
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Fig. 3-4. The anatomical-pathological aspect of oral mucositis: numerous foci of necrotizing microvasculitis with mixed granulo- 
lympomonocytic infiltrate, which mainly involved the arteriole-capillary area.
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contractility. At that stage, laboratory tests showed: erithro-
cytes 2.85x10e3/uL; leukocytes 33,35x10e3/uL, neutrophiles 
71.5%; platelets 297x10e3/uL; haemoglobin 8.7 g/dL; pro-
thrombin activity 50%; antithrombin III 74%; myeloreticu-
lar ratio 12-13; well-represented megakariocytes; absence 
of blast cells. Culture exams did not show the presence of 
salmonella, shigella, etc.
Decease occurred nine days after admission, from sudden 
cardiac arrest, unresponsive to any type of intensive care 
treatment.
The systematic autopsy revealed that the cause of death 
was due to inflammatory aneurysm rupture in the anterior 
descending coronary, with subsequent cardiac tamponade 
(sudden cardiac death of  a mechanical type), and that 
numerous foci of  necrotizing microvasculitis with mixed 
granulo- lympomonocytic infiltrate, which mainly involved 
the arteriole-capillary area, were present at both cutaneous 
and mucosal levels (oropharyngeal mucous membrane). The 
anatomical-pathological and clinical outline suggested a 
typical Kawasaki disease (Figs 1-5).
DISCUSSION
Within Kawasaki disease (KD), oral mucositis – represented 
by diffuse mucous membrane erythema, lip and tongue 
reddening and lingual papillae hypertrophy with subsequent 
development of strawberry tongue – can occur both in the 
acute stage of the disease (0-9 days), and in the convalescen-
ce stage (>25 days) as a consequence of the pharmacological 
treatment. Oral mucositis depends on the typical necrotizing 
microvasculitis with fibrinoid necrosis, which is common 
in Kawasaki disease and connected to an involvement of 
mucous-cutaneous and visceral systemic areas (conjunctival 
and pharyngeal congestion, polymorphous rash, etc.). 
The key pathological evidence of Kawasaki disease (KD) is 
a multi-systemic vasculitis, which mainly involves medium 
calibre arteries (4). Such an involvement is particularly re-
levant because it affects the main coronaries leading to the 
development of aneurysms, which can determine decease 
through the formation of occlusive thrombi or wall rup-
ture, with cardiac tamponade (1,16,19,26). Post-mortem 
morphological studies have shown how the vascular lesions 
vary according to the duration of the disease and the time 
of death. Vasculitis mainly involves microvessels (arterio-
les, capillaries and venules) and small arteries, at the level 
of both the adventitia of medium calibre muscular-elastic 
arteries (perivasculitis), and the systemic connective tissue 
(microvasculitis) (6). Perivasculitis is responsible for the 
subsequent phlogistic involvement of the tunica media of 
muscular-elastic arteries, and therefore for the development 
of aneurysm, whose usual site is the subpericardial coronary 
arterial bed (15).
Necrotizing microvasculitis (fibrinoid necrosis) is observed 
in the systemic connective tissue at the cardiac level, but 
mainly at the cutaneous and at the mucosal levels, and 
represents the typical morphological substratum of mucous-
cutaneous and visceral clinical manifestations of the acute 
stage of the disease. For this reason, KD vascular lesions are 
defined as systemic vasculitis instead of systemic arteritis.
In the acute stage of the disease, circulation shows cytotoxic 
antibodies for the endothelial cells prestimulated by expo-
sure to various cytokines (20). 
Circulating cytotoxic antibodies directed towards com-
Fig.5. A diagnostic image showing coronary and cardiac pathology.
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ponents of neutrophil cytoplasm (ANCA, antineutrophil 
cytotoxic antibodies), which are observed in other forms 
of vasculitis, such as PAN and Wegener’s granulomatosis, 
were also observed in about one third of the children during 
acute KD (20,26).  
There is no specific diagnostic assay for KD; therefore, 
diagnosis is based on clinical criteria, which include fever 
for at least five days and four or more of the five major 
clinical features (i.e., conjunctival injiection, cervical lynpha-
denopathy, oral mucosal changes, polymorphous rash, and 
swelling or rednessof  the extremities), and exclusion of 
alternative diagnoses. Clinical features may not be present 
simultaneously, and taking a careful history is necessary 
in children who lack a clear explanation for fever. If  the 
typical clinical findings are present in a child with fever for 
less than five days, the diagnosis still can be made by expe-
rienced physicians. Because many of the clinical features 
of KD may be present in other illness, exclusion of other 
illness (toxic shock syndrome, Stevens-Johnson syndrome, 
measles, scarlet fever, drug reactions, other febrile viral 
exanthemas, juvenile rheumatoid arthritis, leptospirosis, 
mercury poisoning) in the differential diagnosis often is 
necessary (27-30).
In the case described the diagnosis was made after the death, 
due to the absence of some of the diagnostic criteria, mo-
reover the oral-pharyngeal signs have been probably under 
evaluated (AKD). 
The case of oral mucositis described in this study confirm 
literature data, revealing the morphological substratum 
constituted by microcirculation-necrotizing vasculitis. 
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